000108281 001__ 108281 000108281 005__ 20211115135503.0 000108281 0247_ $$2doi$$a10.1158/1078-0432.CCR-20-2751 000108281 0248_ $$2sideral$$a121002 000108281 037__ $$aART-2020-121002 000108281 041__ $$aeng 000108281 100__ $$0(orcid)0000-0002-8486-8514$$ade Miguel, D. 000108281 245__ $$aTRAIL and Cancer Immunotherapy: Take a Walk on the Short Side 000108281 260__ $$c2020 000108281 5060_ $$aAccess copy available to the general public$$fUnrestricted 000108281 5203_ $$aRecent work shows that TRAILshort, a membrane-bound short form of TRAIL, is expressed by human cancer cells and protects them from TRAIL-induced cell death. AmAbthat selectively targets TRAILshort enhances cancer susceptibility to TRAIL and increases the efficacy of autologous CD8(+) T cells in ex vivo primary tumors. 000108281 536__ $$9info:eu-repo/grantAgreement/ES/DGA-FEDER/B29-17R$$9info:eu-repo/grantAgreement/ES/MCIU-AEI/SAF2017-83120-C2-1-R 000108281 540__ $$9info:eu-repo/semantics/openAccess$$aAll rights reserved$$uhttp://www.europeana.eu/rights/rr-f/ 000108281 590__ $$a12.531$$b2020 000108281 591__ $$aONCOLOGY$$b18 / 242 = 0.074$$c2020$$dQ1$$eT1 000108281 592__ $$a5.426$$b2020 000108281 593__ $$aOncology$$c2020$$dQ1 000108281 593__ $$aCancer Research$$c2020$$dQ1 000108281 655_4 $$ainfo:eu-repo/semantics/other$$vinfo:eu-repo/semantics/acceptedVersion 000108281 700__ $$0(orcid)0000-0003-0154-0730$$aPardo, J.$$uUniversidad de Zaragoza 000108281 7102_ $$11011$$2566$$aUniversidad de Zaragoza$$bDpto. Microb.Ped.Radio.Sal.Pú.$$cÁrea Inmunología 000108281 773__ $$g26, 21 (2020), 5546-5548$$pClin. cancer res.$$tCLINICAL CANCER RESEARCH$$x1078-0432 000108281 8564_ $$s864382$$uhttps://zaguan.unizar.es/record/108281/files/texto_completo.pdf$$yPostprint 000108281 8564_ $$s1035894$$uhttps://zaguan.unizar.es/record/108281/files/texto_completo.jpg?subformat=icon$$xicon$$yPostprint 000108281 909CO $$ooai:zaguan.unizar.es:108281$$particulos$$pdriver 000108281 951__ $$a2021-11-15-08:52:15 000108281 980__ $$aARTICLE